NYT: Johnson & Johnson to pay $33M to resolve claims over drug misrepresentation: 4 things to know

Johnson & Johnson will pay 42 states and Washington, D.C. $33 million through a settlement to resolve claims that the company misrepresented manufacturing practices for several of its over-the-counter drugs, according to The New York Times.

Here are four things to know:

1. In a news release, Illinois Attorney General Lisa Madigan said J&J recalled several medicines, including St. Joseph Aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec and Zyrtec Eye Drops.  Some of these drugs also included children's medications.  

2. The states' attorney generals said the company must also make sure that its marketing and promotional practices do not violate laws when promoting its over-the-counter drugs.

3. In the suit, the states claim McNeil-PPC, a J&J entity, put drugs on that market that violated federal standards, according to NYT.

In a statement, Illinois Attorney General Lisa Madigan said, "Johnson & Johnson's disregard for proper manufacturing practices of children's medications was unacceptable," NYT reports.

4. J&J said the following in a statement, "recalls were precautionary and not undertaken on the basis of any health or safety risks to consumers, and we remain committed to providing consumers with safe and effective over-the-counter medicines."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast